[The period of initial remission in insulin-dependent diabetes. Effect of optimized insulin therapy].
D000293:Adolescent; D000328:Adult; D000375:Aging; D001327:Autoimmune Diseases; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000503:physiopathology; D005260:Female; D006680:HLA Antigens / Q000235:genetics; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000503:physiopathology; D008297:Male
D001786:Blood Glucose; D006680:HLA Antigens; D000949:Histocompatibility Antigens Class II; D007328:Insulin
La phase de rémission initiale du diabète insulino-dépendant. Effet de l'insulinothérapie optimalisée.